| Type | Title | Date Released | |
|---|---|---|---|
6-K | Purchasers Terminate Right to Acquire Up to $12 Million in Additional Shares or Pre-Funded Warrants; Offering Securities Unaffected | ||
SCHEDULE 13G | Orca Capital AG (Filed by) | ||
6-K | China SXT Pharmaceuticals Announces Registered Direct Offering of $12 Million | ||
424B5 | REGISTERED OFFERING | ||
6-K | China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering | ||
6-K | China SXT Pharmaceuticals Terminates Private Placement Offering | ||
EFFECT | Form EFFECT | ||
F-3/A | SHARE RESALE REGISTRATION + SPA | ||
6-K | China SXT Pharmaceuticals Amends Securities Purchase Agreement to Reduce Floor Price | ||
6-K | China SXT Pharmaceuticals Inc. Announces $9 Million Registered Direct Offering | ||
424B5 | REGISTERED OFFERING | ||
F-3 | SHARE RESALE REGISTRATION |